The QED Program is a multi-institutional proof-of-concept program that provides business development support for academic researchers developing early-stage life science and healthcare IT technologies with high commercial potential.
The key goal is to retire the business risk in these early-stage projects, increasing their attractiveness to follow-on investment by established life science companies and private investors.
The QED Program integrates four elements that are critical to successfully and efficiently performing early-stage proof-of-concept technology development: business advice, bridge funding, market drivers and guidance to exit.
The QED Program currently includes the following network of research institutions:
Other organizations are expected to be included in future funding cycles. If your organization is not a current participant, and would like to participate in the program, please contact us at email@example.com.